BeiGene
BGNE
#965
Rank
S$26.89 B
Marketcap
$245.78
Share price
0.49%
Change (1 day)
16.28%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Unfortunately we have no cost to borrow data for this company